Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Develops Scientific Integrity Guide For Staff

This article was originally published in The Gray Sheet

Executive Summary

FDA plans to publicly issue its staff manual on scientific integrity in the near future.

You may also be interested in...



Compassionate Use Study Added To House Approps Orders

House Appropriations Committee wants to better understand issues with denied expanded access requests and requests Government Accountability Office study of FDA efforts in funding bill.

Device Center Scientists Cite Business Interests As A Factor In Decision-Making

Union of Concerned Scientists survey finds that many FDA scientists feel that business interests affect agency decisions. Nevertheless, a strong majority said that the agency is effectively protecting public health.

Regulatory News In Brief

FDA issues documents on advisory committee financial conflicts and scientific integrity. More regulatory updates.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030877

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel